Invex Therapeutics Ltd (ASX:IXC)
0.130
-0.010 (-7.14%)
Apr 29, 2026, 12:28 PM AEST
Invex Therapeutics Market Cap
Invex Therapeutics has a market cap or net worth of 9.77 million as of April 29, 2026. Its market cap has increased by 116.67% in one year.
Market Cap
9.77M
Enterprise Value
5.17M
Revenue
229.08K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
Market Cap Chart
Since July 5, 2019, Invex Therapeutics's market cap has decreased from 59.13M to 9.77M, a decrease of -83.48%. That is a compound annual growth rate of -23.20%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AdAlta | 10.20M |
| Immuron | 10.13M |
| Bio-Gene Technology | 11.29M |
| Cambium Bio | 12.30M |
| Chimeric Therapeutics | 8.84M |
| Biotron | 8.11M |
| Tissue Repair | 7.86M |
| Vectus Biosystems | 7.21M |